August 29, 2014 (www.investorideas.com newswire) Intelligent Highway Solutions, an electrical contracting company building next-gen intelligent transportation systems (ITS) to enhance efficiency of the nation’s roadways, also specializes in electrical installations, temperature control systems, communication/wireless integration, and advanced lighting systems for commercial applications. Earlier this year, the company sharpened its focus on the lighting systems market by securing exclusive distribution rights to proprietary lighting solutions for the legal cannabis industry.
Lighting is a vital component of the growth of the cannabis plant, which in order to flower and ripen needs 24 hours of strong light (when grown indoors) for the first 4-6 weeks of the growth cycle followed by two months of strong light 12.5 hours per day, along with corresponding hours of complete darkness. Growth of the plant and the size of the flower are contingent on the color of light, amount of lux and appropriate heat.
Devon Jones, IHSI CEO, in a recent news release explained that, "Each indoor grower of medical marijuana requires a lighting solution to grow healthy, high yielding cannabis plants. Because lighting is such a significant fixed cost for each grower, every grower is searching for a lighting solution which reduces power consumption while growing healthy plants."
IHSI recently completed testing of its 100-Watt cannabis lighting solution, designed to help cannabis growers reduce costs and improve yields, resulting in an 80% reduction in energy consumption while running at a temperature of approximately 80 degrees (benefits are less operating cost and acceptable temperature emission, which are key variables in plant lighting goals).
The company is also testing a "prototype" 300-Watt light expected to result in significant energy savings as compared to the existing lighting solutions on the market while maintaining an approximate temperature of 80 degrees. IHSI anticipates that by adding more lumens and photon density, the new light will produce large yields for cannabis. The prototype is expected to be installed and tested shortly.
FV Pharma International Corp. (FVPI), the Canadian company which conducted a test on IHSI’s initial lights, is transforming a Canadian factory into a facility that will grow and harvest medical marijuana and will continue to test future IHSI prototypes. FV Pharma Inc. (Canada), affiliate of FVPI, has submitted an application to Health Canada to become a licensed commercial producer of marijuana under the Government of Canada’s new Marijuana for Medical Purposes Regulations. If successful, FV Pharma will receive a license to produce marijuana for medical purposes.
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.
Published at the Investorideas.com Newswire - Big ideas for Global Investors
Disclaimer/ Disclosure:The Investorideas.com newswire is a third party publisher of news and research as well as creates original content as a news source. Original content created by investorideas is protected by copyright laws other than syndication rights. Investorideas is a news source on Google news and Linkedintoday plus hundreds of syndication partners. Our site does not make recommendations for purchases or sale of stocks or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated by featured companies, news submissions, content marketing and online advertising. Contact each company directly for press release questions. Disclosure is posted on each release if required but otherwise the news was not compensated for and is published for the sole interest of our readers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp
BC Residents and Investor Disclaimer : Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.